Prognostic Value of Serum NPY Hypermethylation in Neoadjuvant Chemoradiotherapy for Rectal Cancer: Secondary Analysis of a Randomized Trial
Conclusions:
Meth-ctDNA could be a potential prognostic marker in the neoadjuvant setting and may, if validated, identify patients at increased risk of distant metastases.
Source: American Journal of Clinical Oncology - Category: Cancer & Oncology Tags: Original Articles: Gastrointestinal Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Gastroenterology | Genetics | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Neurology | Rectal Cancers